Login
Merit Medical Systems Inc logo

Merit Medical Systems Inc

merit.com

Merit Medical Systems (NASDAQ: MMSI) is a medical device company that manufactures and sells disposable medical products used in diagnostic and interventional procedures. Revenue is generated through transactional sales of single-use devices to hospitals, clinics, and other healthcare facilities. The company trades on the NASDAQ Global Select Market and has expanded its product portfolio through acquisitions, including businesses and products acquired from Cook Medical Holdings LLC and EndoGastric Solutions, Inc. in 2024, and from Pentax of America, Inc. and Biolife, L.L.C. in 2025, per the FY2025 10-K filed 2026-02-24. Operations are subject to U.S. and global regulatory, reimbursement, and competitive conditions, with supply chain and sterilization processes cited as material operational risks.

Products & Services

Disposable medical products used in diagnostic and interventional procedures. Recent additions include products acquired from Cook Medical Holdings LLC, EndoGastric Solutions Inc. (2024), Pentax of America Inc., and Biolife L.L.C. (2025). Specific product names are not detailed in the available filing excerpts.

Revenue Model

Transactional sales of disposable, single-use medical devices to hospitals and healthcare facilities. The filing excerpts do not provide segment revenue breakdowns or percentage splits.

Customers & Markets

Hospitals, clinics, and healthcare facilities performing diagnostic and interventional procedures. Specific customer concentration data and end-market percentages are not supported by the available filing excerpts.

Geographic Exposure

U.S. and international markets. The filing references U.S. and global political, economic, and regulatory conditions, as well as trade policy and tariff risks, indicating meaningful international exposure. Specific revenue percentages by geography are not supported by the available excerpts.

Financial Snapshot

Revenue
TTM
$1.579B
Gross Margin
TTM
49.47%
Net Income
TTM
$145.6M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
419.82%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
1.680B
Cash
2026 Q2
P/E
TTM
34.84
Free Cash Flow
TTM
$149.4M

Stock Price

Loading...
Market Cap: $5.0713 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support